MCID: MSC044
MIFTS: 27

Muscular Dystrophy-Dystroglycanopathy , Type B, 2

Categories: Genetic diseases, Neuronal diseases, Muscle diseases, Mental diseases, Eye diseases, Metabolic diseases, Fetal diseases, Rare diseases

Aliases & Classifications for Muscular Dystrophy-Dystroglycanopathy , Type B, 2

MalaCards integrated aliases for Muscular Dystrophy-Dystroglycanopathy , Type B, 2:

Name: Muscular Dystrophy-Dystroglycanopathy , Type B, 2 57 13 73
Congenital Muscular Dystrophy-Dystroglycanopathy with Mental Retardation, Type B2 29 6
Mddgb2 57 75
Muscular Dystrophy-Dystroglycanopathy Congenital with Mental Retardation B2 75
Muscular Dystrophy, Congenital, Pomt2-Related 57
Muscular Dystrophy Congenital Pomt2-Related 75

Characteristics:

OMIM:

57
Inheritance:
autosomal recessive

Miscellaneous:
onset at birth or in infancy


HPO:

32
muscular dystrophy-dystroglycanopathy , type b, 2:
Inheritance autosomal recessive inheritance


Classifications:



Summaries for Muscular Dystrophy-Dystroglycanopathy , Type B, 2

OMIM : 57 MDDGB2 is an autosomal recessive congenital muscular dystrophy associated with mental retardation and mild structural brain abnormalities (Yanagisawa et al., 2007). It is part of a group of similar disorders, collectively known as 'dystroglycanopathies,' resulting from defective glycosylation of alpha-dystroglycan (DAG1; 128239) (Godfrey et al., 2007). For a discussion of genetic heterogeneity of congenital muscular dystrophy-dystroglycanopathy type B, see MDDGB1 (613155). (613156)

MalaCards based summary : Muscular Dystrophy-Dystroglycanopathy , Type B, 2, is also known as congenital muscular dystrophy-dystroglycanopathy with mental retardation, type b2, and has symptoms including facial paresis and generalized muscle weakness. An important gene associated with Muscular Dystrophy-Dystroglycanopathy , Type B, 2 is POMT2 (Protein O-Mannosyltransferase 2). Affiliated tissues include brain, tongue and cortex, and related phenotypes are cryptorchidism and micropenis

UniProtKB/Swiss-Prot : 75 Muscular dystrophy-dystroglycanopathy congenital with mental retardation B2: An autosomal recessive disorder characterized by congenital muscular dystrophy associated with mental retardation and mild structural brain abnormalities.

Related Diseases for Muscular Dystrophy-Dystroglycanopathy , Type B, 2

Diseases in the Muscular Dystrophy-Dystroglycanopathy family:

Muscular Dystrophy-Dystroglycanopathy , Type a, 1 Muscular Dystrophy-Dystroglycanopathy , Type a, 3
Muscular Dystrophy-Dystroglycanopathy , Type a, 4 Muscular Dystrophy-Dystroglycanopathy , Type B, 5
Muscular Dystrophy-Dystroglycanopathy , Type C, 5 Muscular Dystrophy-Dystroglycanopathy , Type B, 6
Muscular Dystrophy-Dystroglycanopathy , Type C, 1 Muscular Dystrophy-Dystroglycanopathy , Type C, 4
Muscular Dystrophy-Dystroglycanopathy , Type a, 2 Muscular Dystrophy-Dystroglycanopathy , Type B, 3
Muscular Dystrophy-Dystroglycanopathy , Type B, 4 Muscular Dystrophy-Dystroglycanopathy , Type a, 5
Muscular Dystrophy-Dystroglycanopathy , Type a, 6 Muscular Dystrophy-Dystroglycanopathy , Type B, 1
Muscular Dystrophy-Dystroglycanopathy , Type B, 2 Muscular Dystrophy-Dystroglycanopathy , Type C, 3
Muscular Dystrophy-Dystroglycanopathy , Type C, 2 Muscular Dystrophy-Dystroglycanopathy , Type C, 9
Muscular Dystrophy-Dystroglycanopathy , Type a, 7 Muscular Dystrophy-Dystroglycanopathy , Type a, 8
Muscular Dystrophy-Dystroglycanopathy , Type a, 10 Muscular Dystrophy-Dystroglycanopathy , Type a, 11
Muscular Dystrophy-Dystroglycanopathy , Type a, 12 Muscular Dystrophy-Dystroglycanopathy , Type a, 13
Muscular Dystrophy-Dystroglycanopathy , Type a, 14 Muscular Dystrophy-Dystroglycanopathy , Type B, 14
Muscular Dystrophy-Dystroglycanopathy , Type C, 14 Muscular Dystrophy-Dystroglycanopathy , Type C, 7
Muscular Dystrophy-Dystroglycanopathy , Type C, 12 Muscular Dystrophy-Dystroglycanopathy , Type a, 9

Symptoms & Phenotypes for Muscular Dystrophy-Dystroglycanopathy , Type B, 2

Symptoms via clinical synopsis from OMIM:

57
Respiratory:
respiratory insufficiency

Head And Neck Head:
microcephaly

GenitourinaryInternal GenitaliaMale:
cryptorchidism

Neurologic Central Nervous System:
cerebellar hypoplasia
areflexia
hyporeflexia
hypoplasia of the corpus callosum
delayed motor development
more
Muscle Soft Tissue:
muscular dystrophy
muscle weakness, diffuse
muscle weakness, proximal
muscle hypertrophy
muscle biopsy shows decreased glycosylation of alpha-dystroglycan (dag1, )
more
Cardiovascular Heart:
left ventricular hypertrophy (in some patients)
dilated aortic root (in some patients)
left ventricular wall motion abnormalities (in some patients)
left ventricular systolic dysfunction (in some patients)

Laboratory Abnormalities:
increased serum creatine kinase

Head And Neck Neck:
stiff, hyperextended neck

Skeletal Spine:
scoliosis
lordosis

Head And Neck Eyes:
strabismus
myopia
pigmentary retinopathy (reported in 1 patient)

Skeletal Pelvis:
hip dislocation

Head And Neck Mouth:
open mouth
tongue hypertrophy

Genitourinary External Genitalia Male:
micropenis

Head And Neck Face:
facial muscle weakness

Skeletal:
contractures


Clinical features from OMIM:

613156

Human phenotypes related to Muscular Dystrophy-Dystroglycanopathy , Type B, 2:

32 (show all 30)
# Description HPO Frequency HPO Source Accession
1 cryptorchidism 32 HP:0000028
2 micropenis 32 HP:0000054
3 macroglossia 32 HP:0000158
4 open mouth 32 HP:0000194
5 microcephaly 32 HP:0000252
6 strabismus 32 HP:0000486
7 myopia 32 HP:0000545
8 pigmentary retinopathy 32 occasional (7.5%) HP:0000580
9 intellectual disability 32 HP:0001249
10 hyporeflexia 32 HP:0001265
11 motor delay 32 HP:0001270
12 areflexia 32 HP:0001284
13 generalized hypotonia 32 HP:0001290
14 cerebellar hypoplasia 32 HP:0001321
15 flexion contracture 32 HP:0001371
16 left ventricular hypertrophy 32 occasional (7.5%) HP:0001712
17 hypoplasia of the corpus callosum 32 HP:0002079
18 respiratory insufficiency 32 HP:0002093
19 ventriculomegaly 32 HP:0002119
20 cerebral cortical atrophy 32 HP:0002120
21 scoliosis 32 HP:0002650
22 hip dislocation 32 HP:0002827
23 elevated serum creatine phosphokinase 32 HP:0003236
24 hyperlordosis 32 HP:0003307
25 generalized muscle weakness 32 HP:0003324
26 muscular dystrophy 32 HP:0003560
27 proximal muscle weakness 32 HP:0003701
28 congenital muscular dystrophy 32 HP:0003741
29 facial palsy 32 HP:0010628
30 left ventricular systolic dysfunction 32 occasional (7.5%) HP:0025169

UMLS symptoms related to Muscular Dystrophy-Dystroglycanopathy , Type B, 2:


facial paresis, generalized muscle weakness

Drugs & Therapeutics for Muscular Dystrophy-Dystroglycanopathy , Type B, 2

Search Clinical Trials , NIH Clinical Center for Muscular Dystrophy-Dystroglycanopathy , Type B, 2

Genetic Tests for Muscular Dystrophy-Dystroglycanopathy , Type B, 2

Genetic tests related to Muscular Dystrophy-Dystroglycanopathy , Type B, 2:

# Genetic test Affiliating Genes
1 Congenital Muscular Dystrophy-Dystroglycanopathy with Mental Retardation, Type B2 29 POMT2

Anatomical Context for Muscular Dystrophy-Dystroglycanopathy , Type B, 2

MalaCards organs/tissues related to Muscular Dystrophy-Dystroglycanopathy , Type B, 2:

41
Brain, Tongue, Cortex, Pons

Publications for Muscular Dystrophy-Dystroglycanopathy , Type B, 2

Variations for Muscular Dystrophy-Dystroglycanopathy , Type B, 2

UniProtKB/Swiss-Prot genetic disease variations for Muscular Dystrophy-Dystroglycanopathy , Type B, 2:

75
# Symbol AA change Variation ID SNP ID
1 POMT2 p.Gly246Asp VAR_065039 rs267606966
2 POMT2 p.Tyr666Cys VAR_065045 rs200198778
3 POMT2 p.Phe717Ser VAR_065046
4 POMT2 p.Gly726Glu VAR_065047 rs267606969
5 POMT2 p.Trp748Arg VAR_065048 rs267606964

ClinVar genetic disease variations for Muscular Dystrophy-Dystroglycanopathy , Type B, 2:

6
(show top 50) (show all 104)
# Gene Variation Type Significance SNP ID Assembly Location
1 POMT2 NM_013382.5(POMT2): c.1997A> G (p.Tyr666Cys) single nucleotide variant Pathogenic/Likely pathogenic rs200198778 GRCh37 Chromosome 14, 77745107: 77745107
2 POMT2 NM_013382.5(POMT2): c.1997A> G (p.Tyr666Cys) single nucleotide variant Pathogenic/Likely pathogenic rs200198778 GRCh38 Chromosome 14, 77278764: 77278764
3 POMT2 NM_013382.5(POMT2): c.2177G> A (p.Gly726Glu) single nucleotide variant Pathogenic rs267606969 GRCh37 Chromosome 14, 77743795: 77743795
4 POMT2 NM_013382.5(POMT2): c.2177G> A (p.Gly726Glu) single nucleotide variant Pathogenic rs267606969 GRCh38 Chromosome 14, 77277452: 77277452
5 POMT2 NM_013382.5(POMT2): c.1941G> A (p.Trp647Ter) single nucleotide variant Pathogenic rs267606963 GRCh37 Chromosome 14, 77745163: 77745163
6 POMT2 NM_013382.5(POMT2): c.1941G> A (p.Trp647Ter) single nucleotide variant Pathogenic rs267606963 GRCh38 Chromosome 14, 77278820: 77278820
7 POMT2 NM_013382.5(POMT2): c.593T> A (p.Ile198Asn) single nucleotide variant Pathogenic rs267606972 GRCh37 Chromosome 14, 77769241: 77769241
8 POMT2 NM_013382.5(POMT2): c.593T> A (p.Ile198Asn) single nucleotide variant Pathogenic rs267606972 GRCh38 Chromosome 14, 77302898: 77302898
9 POMT2 NM_013382.5(POMT2): c.737G> A (p.Gly246Asp) single nucleotide variant Pathogenic rs267606966 GRCh37 Chromosome 14, 77767512: 77767512
10 POMT2 NM_013382.5(POMT2): c.737G> A (p.Gly246Asp) single nucleotide variant Pathogenic rs267606966 GRCh38 Chromosome 14, 77301169: 77301169
11 POMT2 NM_013382.5(POMT2): c.1057G> A (p.Gly353Ser) single nucleotide variant Pathogenic rs267606970 GRCh37 Chromosome 14, 77762566: 77762566
12 POMT2 NM_013382.5(POMT2): c.1057G> A (p.Gly353Ser) single nucleotide variant Pathogenic rs267606970 GRCh38 Chromosome 14, 77296223: 77296223
13 POMT2 NM_013382.5(POMT2): c.248+5G> C single nucleotide variant Pathogenic rs587777816 GRCh38 Chromosome 14, 77320429: 77320429
14 POMT2 NM_013382.5(POMT2): c.248+5G> C single nucleotide variant Pathogenic rs587777816 GRCh37 Chromosome 14, 77786772: 77786772
15 POMT2 NM_013382.5(POMT2): c.1683T> C (p.Asn561=) single nucleotide variant Benign/Likely benign rs146307965 GRCh37 Chromosome 14, 77746777: 77746777
16 POMT2 NM_013382.5(POMT2): c.1683T> C (p.Asn561=) single nucleotide variant Benign/Likely benign rs146307965 GRCh38 Chromosome 14, 77280434: 77280434
17 POMT2 NM_013382.5(POMT2): c.1262G> A (p.Arg421Gln) single nucleotide variant Benign/Likely benign rs151078549 GRCh37 Chromosome 14, 77753157: 77753157
18 POMT2 NM_013382.5(POMT2): c.1262G> A (p.Arg421Gln) single nucleotide variant Benign/Likely benign rs151078549 GRCh38 Chromosome 14, 77286814: 77286814
19 POMT2 NM_013382.5(POMT2): c.1404A> G (p.Lys468=) single nucleotide variant Conflicting interpretations of pathogenicity rs150491326 GRCh37 Chromosome 14, 77751904: 77751904
20 POMT2 NM_013382.5(POMT2): c.1404A> G (p.Lys468=) single nucleotide variant Conflicting interpretations of pathogenicity rs150491326 GRCh38 Chromosome 14, 77285561: 77285561
21 POMT2 NM_013382.5(POMT2): c.1701C> G (p.Pro567=) single nucleotide variant Conflicting interpretations of pathogenicity rs151051452 GRCh37 Chromosome 14, 77746759: 77746759
22 POMT2 NM_013382.5(POMT2): c.1701C> G (p.Pro567=) single nucleotide variant Conflicting interpretations of pathogenicity rs151051452 GRCh38 Chromosome 14, 77280416: 77280416
23 POMT2 NM_013382.5(POMT2): c.1881G> A (p.Ala627=) single nucleotide variant Conflicting interpretations of pathogenicity rs146588608 GRCh37 Chromosome 14, 77746176: 77746176
24 POMT2 NM_013382.5(POMT2): c.1881G> A (p.Ala627=) single nucleotide variant Conflicting interpretations of pathogenicity rs146588608 GRCh38 Chromosome 14, 77279833: 77279833
25 POMT2 NM_013382.5(POMT2): c.1903G> A (p.Val635Ile) single nucleotide variant Uncertain significance rs142299878 GRCh37 Chromosome 14, 77745201: 77745201
26 POMT2 NM_013382.5(POMT2): c.1903G> A (p.Val635Ile) single nucleotide variant Uncertain significance rs142299878 GRCh38 Chromosome 14, 77278858: 77278858
27 POMT2 NM_013382.5(POMT2): c.652G> A (p.Asp218Asn) single nucleotide variant Conflicting interpretations of pathogenicity rs140785104 GRCh37 Chromosome 14, 77769182: 77769182
28 POMT2 NM_013382.5(POMT2): c.652G> A (p.Asp218Asn) single nucleotide variant Conflicting interpretations of pathogenicity rs140785104 GRCh38 Chromosome 14, 77302839: 77302839
29 POMT2 NM_013382.5(POMT2): c.1537A> G (p.Asn513Asp) single nucleotide variant Conflicting interpretations of pathogenicity rs117173425 GRCh38 Chromosome 14, 77284989: 77284989
30 POMT2 NM_013382.5(POMT2): c.1537A> G (p.Asn513Asp) single nucleotide variant Conflicting interpretations of pathogenicity rs117173425 GRCh37 Chromosome 14, 77751332: 77751332
31 POMT2 NM_013382.5(POMT2): c.1250A> G (p.Lys417Arg) single nucleotide variant Conflicting interpretations of pathogenicity rs147268052 GRCh38 Chromosome 14, 77288765: 77288765
32 POMT2 NM_013382.5(POMT2): c.1250A> G (p.Lys417Arg) single nucleotide variant Conflicting interpretations of pathogenicity rs147268052 GRCh37 Chromosome 14, 77755108: 77755108
33 POMT2 NM_013382.5(POMT2): c.1045_1052delCGGATGGCinsG (p.Arg349Alafs) indel Pathogenic rs886042094 GRCh37 Chromosome 14, 77762571: 77762578
34 POMT2 NM_013382.5(POMT2): c.1045_1052delCGGATGGCinsG (p.Arg349Alafs) indel Pathogenic rs886042094 GRCh38 Chromosome 14, 77296228: 77296235
35 POMT2 NM_013382.5(POMT2): c.1920C> T (p.Gly640=) single nucleotide variant Uncertain significance rs150755807 GRCh37 Chromosome 14, 77745184: 77745184
36 POMT2 NM_013382.5(POMT2): c.1920C> T (p.Gly640=) single nucleotide variant Uncertain significance rs150755807 GRCh38 Chromosome 14, 77278841: 77278841
37 POMT2 NM_013382.5(POMT2): c.2057G> A (p.Arg686Gln) single nucleotide variant Benign/Likely benign rs200163818 GRCh37 Chromosome 14, 77744827: 77744827
38 POMT2 NM_013382.5(POMT2): c.2057G> A (p.Arg686Gln) single nucleotide variant Benign/Likely benign rs200163818 GRCh38 Chromosome 14, 77278484: 77278484
39 POMT2 NM_013382.5(POMT2): c.649G> A (p.Ala217Thr) single nucleotide variant Conflicting interpretations of pathogenicity rs144748043 GRCh37 Chromosome 14, 77769185: 77769185
40 POMT2 NM_013382.5(POMT2): c.649G> A (p.Ala217Thr) single nucleotide variant Conflicting interpretations of pathogenicity rs144748043 GRCh38 Chromosome 14, 77302842: 77302842
41 POMT2 NM_013382.5(POMT2): c.1935C> T (p.Leu645=) single nucleotide variant Conflicting interpretations of pathogenicity rs141193672 GRCh37 Chromosome 14, 77745169: 77745169
42 POMT2 NM_013382.5(POMT2): c.1935C> T (p.Leu645=) single nucleotide variant Conflicting interpretations of pathogenicity rs141193672 GRCh38 Chromosome 14, 77278826: 77278826
43 POMT2 NM_013382.5(POMT2): c.66C> T (p.Gly22=) single nucleotide variant Conflicting interpretations of pathogenicity rs200670377 GRCh37 Chromosome 14, 77786959: 77786959
44 POMT2 NM_013382.5(POMT2): c.66C> T (p.Gly22=) single nucleotide variant Conflicting interpretations of pathogenicity rs200670377 GRCh38 Chromosome 14, 77320616: 77320616
45 POMT2 NM_013382.5(POMT2): c.1824C> T (p.Tyr608=) single nucleotide variant Conflicting interpretations of pathogenicity rs759220971 GRCh37 Chromosome 14, 77746233: 77746233
46 POMT2 NM_013382.5(POMT2): c.1824C> T (p.Tyr608=) single nucleotide variant Conflicting interpretations of pathogenicity rs759220971 GRCh38 Chromosome 14, 77279890: 77279890
47 POMT2 NM_013382.5(POMT2): c.1593G> A (p.Leu531=) single nucleotide variant Benign/Likely benign rs147934334 GRCh37 Chromosome 14, 77750200: 77750200
48 POMT2 NM_013382.5(POMT2): c.1593G> A (p.Leu531=) single nucleotide variant Benign/Likely benign rs147934334 GRCh38 Chromosome 14, 77283857: 77283857
49 POMT2 NM_013382.5(POMT2): c.958C> T (p.Gln320Ter) single nucleotide variant Pathogenic rs775932206 GRCh37 Chromosome 14, 77765080: 77765080
50 POMT2 NM_013382.5(POMT2): c.958C> T (p.Gln320Ter) single nucleotide variant Pathogenic rs775932206 GRCh38 Chromosome 14, 77298737: 77298737

Expression for Muscular Dystrophy-Dystroglycanopathy , Type B, 2

Search GEO for disease gene expression data for Muscular Dystrophy-Dystroglycanopathy , Type B, 2.

Pathways for Muscular Dystrophy-Dystroglycanopathy , Type B, 2

GO Terms for Muscular Dystrophy-Dystroglycanopathy , Type B, 2

Sources for Muscular Dystrophy-Dystroglycanopathy , Type B, 2

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....